1. Pimple S, Mishra G. Cancer cervix: Epidemiology and disease burden. CytoJournal. 2022;19:21.
2. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003;9(5):348-59.
3. Paaso A, Jaakola A, Syrjänen S, Louvanto K. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity. Acta Cytol. 2019;63(2):148-58.
4. Mahdi BM. Introductory chapter: concept of human leukocyte antigen (HLA). human leukocyte antigen (HLA). 2019 Jan 18:1-8.5.
5. Suzuki K, Luo Y. Histone Acetylation and the Regulation of Major Histocompatibility Class II Gene Expression. Adv Protein Chem Struct Biol. 2017;106:71-111.
6. Kamiza AB, Kamiza S, Mathew CG. HLA-DRB1 alleles and cervical cancer: A meta-analysis of 36 case-control studies. Cancer Epidemiol. 2020;67:101748.
7. Latsoudis H, Stylianakis E, Mavroudi I, Kanterakis A, Pavlidis P, Georgopoulou A, Batsali A, et al. Significance of regional population HLA immunogenetic datasets in the efficacy of umbilical cord blood banks and marrow donor registries: a study of Cretan HLA genetic diversity. Cytotherapy. 2022;24(2):183-92.
8. Chambuso R, Ramesar R, Kaambo E, Denny L, Passmore JA, Williamson AL, et al. Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa. J Cancer. 2019;10(10):2145-52.
9. Kim N, Kwon JS, Kang WH, Yeom SI. High-Resolution Melting (HRM) Genotyping. Methods Mol Biol. 2023;2638:337-49.
10. Smith RA, Lam AK. Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma: Clinical Significance and Detection by High-Resolution Melting. Methods Mol Biol. 2022;2534: 149-59.
11. Wittwer CT, Hemmert AC, Kent JO, Rejali NA. DNA melting analysis. Mol Aspects Med. 2024;97.
12. Tucker EJ, Huynh BL. Genotyping by high-resolution melting analysis. Methods Mol Biol 2014;1145:59-66.
13. Zhang L, Ma X, You G, Zhang X, Fu Q. A novel multiplex HRM assay to detect clopidogrel resistance. Sci Rep. 2017;22 (1):16021.
14. Nathalang O, Intharanut K, Chidtrakoon S. High-resolution melting curve analysis to predict extended blood group phenotypes among Thai donors and patients. Transfus Med Hemother. 2022;22 (3):163-71.
15. Smith JM, S. N. a. J. T., HLA-DRB1*13 and its associated alleles are linked with persistent human papillomavirus (HPV) 16 infection. J Med Microbiol. 2015;64:530-6.
16. Wang SS TM, Schiffman M. Human leukocyte antigen (HLA) class I DRB1*04 alleles protect against persistent cervical neoplasia in women coinfected with oncogenic human papillomavirus (HPV) types. J Infect Dis. 2017;216(4):474-8.
17. Zhang QX, Zhong A. Association between human leukocyte antigen variants and human papillomavirus 16-positive cervical cancer. Biomed Res Int. 2018;16;570-81.
18. Bouza E, Martín Jiménez M, Alemany L, Arribas J, Bañares R, Barragán MB, et al. Overview of virus and cancer relationships. Position paper. Rev Esp Quimioter. 2021;34(6):525-55.
19. Chan PK, Cheung JL, Cheung TH, Lin CK, Siu SS, Yu MM, et al. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol. 2007;105(3):736-41.
20. Delahaye-Sourdeix M, Urayama KY, Gaborieau V, Veenstra R, Foll M, Chabrier A, Benavente Y, et al. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev. 2015;24(12):1838-43.